T1	Food 0 7	Avocado
T2	Physiology 46 68	Oral Glucose Tolerance
T3	Physiology 21 40	Abdominal Adiposity
T4	DECREASES 1598 1607	reduction
T5	Disease 88 98	Overweight
T6	Disease 103 110	Obesity
T7	Methodology 793 796	DXA
T8	Food 151 163	Hass avocado
T9	Food 254 261	avocado
T10	Physiology 277 296	abdominal adiposity
T11	Food 361 368	avocado
T12	Food 1941 1953	Hass avocado
T13	Physiology 1858 1877	abdominal adiposity
T14	Physiology 1881 1898	glycemic outcomes
T15	Population 530 536	adults
T16	IMPROVES 201 206	lower
T17	Disease 207 224	abdominal obesity
T18	Physiology 301 318	glycemic outcomes
T19	Physiology 384 403	abdominal adiposity
T20	Disease 405 423	insulin resistance
T21	Measurement 425 452	oral-glucose-tolerance test
T22	Measurement 454 458	OGTT
T23	Physiology 475 490	β-cell function
T24	Methodology 1187 1191	OGTT
T25	Population 2001 2008	females
T26	Measurement 568 571	BMI
T27	Methodology 793 796	DXA
T28	Physiology 840 859	abdominal adiposity
T29	Physiology 861 884	visceral adipose tissue
T30	Physiology 886 889	VAT
T31	Physiology 892 929	subcutaneous abdominal adipose tissue
T32	Physiology 931 935	SAAT
T33	Measurement 946 966	ratio of VAT to SAAT
T34	Measurement 968 976	VS Ratio
T35	Chemical 987 994	glucose
T36	Chemical 999 1006	insulin
T38	Methodology 1239 1245	ANCOVA
T39	Physiology 1290 1293	sex
T40	AFFECTS 1954 1961	changed
T41	Physiology 1962 1981	abdominal adiposity
T42	Physiology 14607 14625	glycemic variables
T43	Measurement 15590 15598	VS Ratio
T44	Disease 2116 2126	overweight
T45	Disease 2131 2138	obesity
T46	Physiology 2082 2097	β-cell function
T47	Physiology 2048 2078	peripheral insulin sensitivity
T48	IMPROVES 2032 2044	improvements
T49	Population 2104 2138	adults with overweight and obesity
T50	Population 1786 1791	males
T51	Population 1549 1556	females
T52	Disease 1051 1069	insulin resistance
T53	Measurement 1071 1078	HOMA-IR
T54	Physiology 1085 1104	insulin sensitivity
T55	Measurement 1106 1119	Matsuda index
T56	Physiology 1125 1140	β-cell function
T57	Measurement 1142 1161	Insulinogenic index
T58	DECREASES 1341 1350	reduction
T59	Physiology 1354 1358	SAAT
T60	Physiology 1611 1614	VAT
T61	Food 673 685	Hass avocado
T62	Measurement 1696 1704	VS Ratio
T63	Food 766 781	without avocado
T64	Measurement 15132 15145	Matsuda index
T65	AFFECTS 350 357	effects
T66	INCREASES 1443 1451	increase
T67	Measurement 1455 1463	VS Ratio
T68	Population 75 110	Persons with Overweight and Obesity
T69	AFFECTS 243 250	effects
T70	Disease 15250 15260	overweight
T71	Population 15237 15260	Persons with overweight
T72	Disease 15305 15312	obesity
T73	Population 15237 15249;15305 15312	Persons with obesity
T74	Population 15355 15364;15383 15389	Caucasian female
T75	Physiology 15424 15433	adiposity
T77	Population 15479 15486	females
T78	Physiology 15498 15502	SAAT
T79	Population 15571 15576	males
T81	Physiology 15688 15691	VAT
T82	Population 15700 15705	males
T83	Population 15710 15717	females
T84	Population 15736 15743	females
T85	Population 15776 15781	males
T87	Physiology 16639 16656	central adiposity
T88	Measurement 18803 18811	VS Ratio
T89	Measurement 16017 16040	physical activity score
T91	Physiology 16685 16694	adiposity
T92	Disease 16779 16797	insulin resistance
T93	Physiology 16779 16786;16802 16813	insulin sensitivity
T94	Physiology 16894 16903	adiposity
T95	Physiology 16908 16925	glycemic outcomes
T98	Physiology 17006 17009	VAT
T99	Physiology 17069 17073	SAAT
T101	Measurement 17138 17146	VS Ratio
T103	Population 17204 17211	females
T104	Physiology 17277 17280	VAT
T105	Physiology 17282 17286	SAAT
T106	Measurement 17292 17300	VS Ratio
T107	Population 17327 17332	males
T108	Physiology 17399 17402	VAT
T109	Physiology 17404 17408	SAAT
T110	Measurement 17414 17422	VS Ratio
T111	Measurement 17485 17493	VS Ratio
T113	Measurement 17572 17580	VS Ratio
T114	Physiology 17585 17589	SAAT
T115	Population 17596 17603	females
T116	Disease 17669 17687	insulin resistance
T117	Physiology 17669 17676;17692 17703	insulin sensitivity
T118	Chemical 17732 17739	glucose
T119	Chemical 17745 17752	insulin
T121	Measurement 17923 17930	HOMA-IR
T122	Measurement 17944 17957	Matsuda index
T123	Chemical 17979 17982	IGI
T124	Population 18034 18041	females
T125	Population 18045 18050	males
T126	Physiology 18101 18118	central adiposity
T127	Physiology 18152 18161	adiposity
T128	Population 18295 18302	females
T129	Population 18307 18312	males
T130	Population 18341 18348	females
T131	Population 18353 18358	males
T133	Physiology 18423 18426	VAT
T134	Physiology 18497 18501	SAAT
T135	Measurement 18565 18573	VS Ratio
T137	Population 18643 18650	females
T139	Physiology 18717 18720	VAT
T141	Physiology 18781 18785	SAAT
T142	Population 18850 18855	males
T144	Physiology 18922 18925	VAT
T145	Physiology 18939 18943	SAAT
T146	Measurement 18961 18969	VS Ratio
T148	Measurement 19056 19064	VS Ratio
T149	Physiology 19069 19073	SAAT
T150	Population 19080 19087	females
T151	Disease 19123 19141	insulin resistance
T152	Physiology 19123 19130;19146 19157	insulin sensitivity
T153	Measurement 19222 19229	HOMA-IR
T155	Measurement 19317 19330	Matsuda index
T156	Chemical 19351 19354	IGI
T157	Population 19396 19403	females
T158	Population 19423 19428	males
T160	Physiology 19532 19549	glycemic outcomes
T2411	Physiology 14593 14602	adiposity
T2511	Physiology 14808 14817	adiposity
T5811	Physiology 14957 14966	adiposity
T6111	Methodology 15093 15097	OGTT
T6311	Measurement 15123 15130	HOMA-IR
T6611	Chemical 15151 15154	IGI
E1	IMPROVES:T16 Agent:T8 Theme:T17
E3	AFFECTS:T40 Agent:T12 Theme:T41
E4	IMPROVES:T48 Theme:T47 Agent:T12
E5	IMPROVES:T48 Theme:T46 Agent:T12
E7	DECREASES:T4 Theme:T60 Agent:T61
E8	DECREASES:T58 Agent:T63 Theme:T59
E9	DECREASES:T4 Theme:T62 Agent:T61
E10	INCREASES:T66 Agent:T63 Theme:T67
E11	AFFECTS:T65 Agent:T11 Theme:T19
E12	AFFECTS:T65 Agent:T11 Theme:T20
E13	AFFECTS:T65 Agent:T11 Theme:T21
E14	AFFECTS:T65 Agent:T11 Theme:T23
E15	AFFECTS:T69 Agent:T9 Theme:T10
E16	AFFECTS:T69 Agent:T9 Theme:T18
A1	Factuality E4 Negated
A2	Factuality E5 Negated
A3	Factuality E11 Unknown
A4	Factuality E12 Unknown
A5	Factuality E13 Unknown
A6	Factuality E14 Unknown
A7	Factuality E15 Unknown
A8	Factuality E16 Unknown
N1	Reference T1 FOODON:00003600	avocado (whole)
N2	Reference T2 MESH:D005951	Glucose Tolerance Test
N3	Reference T3 NCIT:C139218	Abdominal Fat
N4	Reference T5 NCIT:C94250	Overweight
N5	Reference T6 NCIT:C3283	Obesity
N6	Reference T8 FOODON:00002982	hass avocado
N7	Reference T9 FOODON:00003600	avocado (whole)
N8	Reference T10 NCIT:C139218	Abdominal Fat
N9	Reference T11 FOODON:00003600	avocado (whole)
N10	Reference T12 FOODON:00002982	hass avocado
N11	Reference T13 NCIT:C139218	Abdominal Fat
N12	Reference T17 MESH:D056128	Obesity, Abdominal
N13	Reference T19 NCIT:C139218	Abdominal Fat
N14	Reference T20 NCIT:C113101	Insulin Resistance
N15	Reference T21 MESH:D005951	Glucose Tolerance Test
N16	Reference T22 MESH:D005951	Glucose Tolerance Test
N17	Reference T23 NCIT:C123455	Beta-Cell Function Measurement
N18	Reference T26 NCIT:C16358	Body Mass Index
N19	Reference T28 NCIT:C139218	Abdominal Fat
N20	Reference T29 MESH:D050152	Intra-Abdominal Fat
N21	Reference T30 MESH:D050152	Intra-Abdominal Fat
N22	Reference T31 MESH:D050507	Subcutaneous Fat, Abdominal
N23	Reference T32 MESH:D050507	Subcutaneous Fat, Abdominal
N24	Reference T35 CHEBI:17234	glucose
N25	Reference T36 NCIT:C2271	Insulin
N26	Reference T39 NCIT:C28421	Sex
N27	Reference T41 NCIT:C139218	Abdominal Fat
N28	Reference T44 NCIT:C94250	Overweight
N29	Reference T45 NCIT:C3283	Obesity
N30	Reference T46 NCIT:C123455	Beta-Cell Function Measurement
N31	Reference T47 MESH:D007333	Insulin Resistance
N32	Reference T52 NCIT:C113101	Insulin Resistance
N33	Reference T53 NCIT:C100447	Homeostatic Model Assessment of Insulin Resistance
N34	Reference T54 OCHV:C0920563	insulin sensitivity
N35	Reference T56 NCIT:C123455	Beta-Cell Function Measurement
N36	Reference T59 MESH:D050507	Subcutaneous Fat, Abdominal
N37	Reference T60 MESH:D050152	Intra-Abdominal Fat
N38	Reference T61 FOODON:00002982	hass avocado
N39	Reference T70 NCIT:C94250	Overweight
N40	Reference T72 NCIT:C3283	Obesity
N41	Reference T75 MESH:D050154	Adiposity
N42	Reference T78 MESH:D050507	Subcutaneous Fat, Abdominal
N43	Reference T81 MESH:D050152	Intra-Abdominal Fat
N44	Reference T87 NCIT:C120381	Central Obesity
N45	Reference T89 NCIT:C17708	Physical Activity
N46	Reference T91 MESH:D050154	Adiposity
N47	Reference T92 NCIT:C113101	Insulin Resistance
N48	Reference T93 OCHV:C0920563	insulin sensitivity
N49	Reference T94 MESH:D050154	Adiposity
N50	Reference T98 MESH:D050152	Intra-Abdominal Fat
N51	Reference T99 MESH:D050507	Subcutaneous Fat, Abdominal
N52	Reference T104 MESH:D050152	Intra-Abdominal Fat
N53	Reference T105 MESH:D050507	Subcutaneous Fat, Abdominal
N54	Reference T108 MESH:D050152	Intra-Abdominal Fat
N55	Reference T109 MESH:D050507	Subcutaneous Fat, Abdominal
N56	Reference T114 MESH:D050507	Subcutaneous Fat, Abdominal
N57	Reference T116 NCIT:C113101	Insulin Resistance
N58	Reference T117 OCHV:C0920563	insulin sensitivity
N59	Reference T118 CHEBI:17234	glucose
N60	Reference T119 NCIT:C2271	Insulin
N61	Reference T121 NCIT:C100447	Homeostatic Model Assessment of Insulin Resistance
N62	Reference T126 NCIT:C120381	Central Obesity
N63	Reference T127 MESH:D050154	Adiposity
N64	Reference T133 MESH:D050152	Intra-Abdominal Fat
N65	Reference T134 MESH:D050507	Subcutaneous Fat, Abdominal
N66	Reference T139 MESH:D050152	Intra-Abdominal Fat
N67	Reference T141 MESH:D050507	Subcutaneous Fat, Abdominal
N68	Reference T144 MESH:D050152	Intra-Abdominal Fat
N69	Reference T145 MESH:D050507	Subcutaneous Fat, Abdominal
N70	Reference T149 MESH:D050507	Subcutaneous Fat, Abdominal
N71	Reference T151 NCIT:C113101	Insulin Resistance
N72	Reference T152 OCHV:C0920563	insulin sensitivity
N73	Reference T153 NCIT:C100447	Homeostatic Model Assessment of Insulin Resistance
N74	Reference T2411 MESH:D050154	Adiposity
N75	Reference T2511 MESH:D050154	Adiposity
N76	Reference T5811 MESH:D050154	Adiposity
N77	Reference T6311 NCIT:C100447	Homeostatic Model Assessment of Insulin Resistance
